MTOR and metabolic dysfunction-associated steatotic liver disease: Another experiment showed that inhibition of ghrelin o-acyltransferase could block the inflammatory response by regulating the mTOR pathway and thus reduce hepatic cell steatosis, which confirmed that mTOR can affect NAFLD by regulating the inflammatory response [98] (Figure 3).